<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="37816" whole_study_id="19692" phs="001135" v="2" p="1" createDate="2020-02-19T17:44:58-05:00" completedByGPADate="2020-02-21T18:14:06-05:00" modDate="2020-09-14T22:13:47-05:00" maxParentChildStudyModDate="2020-09-14T22:13:47-05:00" handle="START" num_participants="804"><StudyInfo accession="phs001135.v2.p1" parentAccession="phs001135.v2.p1"><BioProject id="PRJNA324306" entrez_id="324306" type="bp_admin_access"/><BioProject id="PRJNA324307" entrez_id="324307" type="bp_data_submission"/><StudyNameEntrez>Starting Treatment with Agonist Replacement Therapy (START)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="Yes"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="array_multi_sample_gen"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="dna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>dna</StudyType><StudyType>snp_array</StudyType><StudyType>array_derived_genotypes</StudyType><StudyType>analysis</StudyType></StudyTypes><Funding>R21 DA036808 and K01 DA036751</Funding></StudyInfo><Authority><ICs><IC id="17" name="NIDA" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="WBERRETTINI" aid="2" auth="eRA" login="WBERRETTINI" fname="Wade" mname="" lname="Berrettini" email="WADEB@MAIL.MED.UPENN.EDU"><Role>PI</Role><Organization>UNIVERSITY OF PENNSYLVANIA</Organization></Person><Person nedid="0010045556" aid="1" auth="cit" login="jpollock" fname="Jonathan" mname="D" lname="Pollock" email="jpollock@ngmsmtp.nida.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="JOHN_RICE" aid="2" auth="eRA" login="JOHN_RICE" fname="John" mname="P." lname="Rice" email="john@zork.wustl.edu"><Role>PI_ASSIST</Role><Organization>WASHINGTON UNIVERSITY</Organization></Person><Person nedid="2002777465" aid="1" auth="cit" login="wuz8" fname="Zhuoxi" mname="" lname="Wu" email="joe.wu@nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0010045556" aid="1" auth="cit" login="jpollock" fname="Jonathan" mname="D" lname="Pollock" email="jpollock@ngmsmtp.nida.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>Main START study funding came from the National Institute on Drug Abuse through
the Clinical Trials Network (CTN) through a series of grants provided to each
participating node: the Pacific Northwest Node (U10 DA01714), the Oregon Hawaii
Node (U10 DA013036), the California/Arizona Node (U10 DA015815), the New
England Node (U10 DA13038), the Delaware Valley Node (U10 DA13043), the Pacific
Region Node (U10 DA13045), and the New York Node (U10 DA013046). Funding
support for the genotyping was provided by the National Institute on Drug Abuse</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="2023" CGType="cg_class_GRU" title="General Research Use" name="GRU" dac_uid="57" dac_name="JAAMH" irb-approval-required="No"><Use-Restriction>Use of the data is limited only by the terms of the model Data Use Certification.

For Scientific Research Only</Use-Restriction></ConsentGroup><ConsentGroupLinks><ConsentGroupLink cg_uid_from="2023"><StudyTo study_uid="10253" name="dbGaP Collection: Compilation of Individual-Level Genomic Data for General Research Use" accession="phs000688.v1"><ConsentGroupTo uid="1115" name="GRU"/></StudyTo></ConsentGroupLink></ConsentGroupLinks></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="19692" whole_study_id="19692" phs="001135" v="1" p="1" createDate="2016-05-26T11:39:45-05:00" completedByGPADate="2016-05-26T14:54:11-05:00" modDate="2020-09-01T10:52:12-05:00" maxParentChildStudyModDate="2020-09-01T10:52:12-05:00" handle="START" num_participants="804"><StudyInfo accession="phs001135.v1.p1" parentAccession="phs001135.v1.p1"><BioProject id="PRJNA324306" entrez_id="324306" type="bp_admin_access"/><BioProject id="PRJNA324307" entrez_id="324307" type="bp_data_submission"/><StudyNameEntrez>Starting Treatment with Agonist Replacement Therapy (START)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="Yes"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="array_multi_sample_gen"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="dna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>dna</StudyType><StudyType>snp_array</StudyType><StudyType>array_derived_genotypes</StudyType><StudyType>analysis</StudyType></StudyTypes><Funding>R21 DA036808 and K01 DA036751</Funding></StudyInfo><Authority><ICs><IC id="17" name="NIDA" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="WBERRETTINI" aid="2" auth="eRA" login="WBERRETTINI" fname="Wade" mname="" lname="Berrettini" email="WADEB@MAIL.MED.UPENN.EDU"><Role>PI</Role><Organization>UNIVERSITY OF PENNSYLVANIA</Organization></Person><Person nedid="0010045556" aid="1" auth="cit" login="jpollock" fname="Jonathan" mname="D" lname="Pollock" email="jpollock@ngmsmtp.nida.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="JOHN_RICE" aid="2" auth="eRA" login="JOHN_RICE" fname="John" mname="P." lname="Rice" email="john@zork.wustl.edu"><Role>PI_ASSIST</Role><Organization>WASHINGTON UNIVERSITY</Organization></Person><Person nedid="0013043239" aid="1" auth="cit" login="pretels" fname="Renate" mname="S" lname="Pretel" email="pretels@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0010045556" aid="1" auth="cit" login="jpollock" fname="Jonathan" mname="D" lname="Pollock" email="jpollock@ngmsmtp.nida.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>Main START study funding came from the National Institute on Drug Abuse through
the Clinical Trials Network (CTN) through a series of grants provided to each
participating node: the Pacific Northwest Node (U10 DA01714), the Oregon Hawaii
Node (U10 DA013036), the California/Arizona Node (U10 DA015815), the New
England Node (U10 DA13038), the Delaware Valley Node (U10 DA13043), the Pacific
Region Node (U10 DA13045), and the New York Node (U10 DA013046). Funding
support for the genotyping was provided by the National Institute on Drug Abuse</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="2023" CGType="cg_class_GRU" title="General Research Use" name="GRU" dac_uid="57" dac_name="JAAMH" irb-approval-required="No"><Use-Restriction>Use of the data is limited only by the terms of the model Data Use Certification.

For Scientific Research Only</Use-Restriction></ConsentGroup><ConsentGroupLinks><ConsentGroupLink cg_uid_from="2023"><StudyTo study_uid="10253" name="dbGaP Collection: Compilation of Individual-Level Genomic Data for General Research Use" accession="phs000688.v1"><ConsentGroupTo uid="1115" name="GRU"/></StudyTo></ConsentGroupLink></ConsentGroupLinks></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>